MedTrace Logo

Health Outcomes and Costs (HOC) in Lung Cancer (LC)

NCT02363101 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2015-03-04

No results posted yet for this study

Summary

The purpose of this study is to evaluate the costs, health-related quality of life and preference values from lung cancer patients assisted in a Brazilian public health care unit.

Conditions

Sponsors & Collaborators

  • Instituto Nacional de Cardiologia de Laranjeiras

    collaborator OTHER

  • Instituto Nacional de Cancer, Brazil

    lead OTHER_GOV

Principal Investigators

  • Carlos Gil Ferreira · National Cancer Institute, France

  • Luciene Schluckebier · National Cancer Institute, France

  • Marisa Santos · INC

  • Bruna Carvalho · National Cancer Institute, France

  • Pedro Masson · National Cancer Institute, France

  • Andréa Monteiro · INC

  • Bruna Medeiros · INC

  • Kátia Senna · INC

  • Márcia Gisele · INC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2016-03-31
Completion
2016-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02363101 on ClinicalTrials.gov